Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.70 |
| ▸ | GNAI3 | P08754 | 6/20 | 0.61 |
| ▸ | GNAO1 | P09471 | 6/20 | 0.61 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.61 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | GUSB | P08236 | 2/20 | 0.48 |
| ▸ | EBP | Q15125 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28154297 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1187251 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1261593 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1261675 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1261708 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL6114812 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL4907893 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1564984 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1262700 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL28106520 | 1.00 | HRH3 (0.70) | HRH3GNAI3GNAO1GNAI1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250196021-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-06-19 | — | — | US | claimed |
| WO-2025128828-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-06-19 | — | — | WO | claimed |
| CN-107427758-B | Separation using ionic liquid solvents | 切弗朗菲利浦化学公司 | 2020-11-20 | — | — | CN | claimed |
| US-10836874-B2 | High performance cross-linked triblock cationic functionalized polymer for electrochemical applications, methods of making and methods of using | COLORADO SCHOOL OF MINES (US) | 2020-11-17 | — | — | US | claimed |
| US-20190100633-A1 | HIGH PERFORMANCE CROSS-LINKED TRIBLOCK CATIONIC FUNCTIONALIZED POLYMER FOR ELECTROCHEMICAL APPLICATIONS, METHODS OF MAKING AND METHODS OF USING | UNIVERSITY OF MASSACHUSETTS | 2019-04-04 | — | — | US | claimed |
| US-10227274-B2 | Separations with ionic liquid solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2019-03-12 | — | — | US | claimed |
| CN-107427758-A | Utilize the separation of ion liquid solvent | 切弗朗菲利浦化学公司 | 2017-12-01 | — | — | CN | claimed |
| EP-3244987-A1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | Chevron Phillips Chemical Company LP (US) | 2017-11-22 | — | — | EP | claimed |
| CN-106935907-A | Lithium metal battery | 三星电子株式会社 | 2017-07-07 | — | — | CN | claimed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | claimed |
| WO-2007149748-A1 | ANTISTATIC AGENT AND PLASTIC COMPOSITION COMPRISING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-12-27 | — | — | WO | claimed |
| US-20060247472-A1 | Method for purifying quaternary onium salts | HONEYWELL INTERNATIONAL INC. (US) | 2006-11-02 | — | — | US | claimed |
| US-5232978-A | 1-(2-arylethyl)-pyrrolidines | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-08-03 | — | — | US | claimed |
| EP-0483580-A2 | 1-(2-Arylethyl)-pyrrolidine | MERCK PATENT GmbH (DE) | 1992-05-06 | — | — | EP | claimed |
| JP-2215769-A | — | — | None | — | — | JP | disclosed |
| JP-4264067-A | — | — | None | — | — | JP | disclosed |
| JP-4264067-A | — | — | None | — | — | JP | disclosed |
| EP-0483580-A2 | 1-(2-Arylethyl)-pyrrolidine | MERCK PATENT GmbH (DE) | 1992-05-06 | — | — | EP | disclosed |
| EP-0483580-A2 | 1-(2-Arylethyl)-pyrrolidine | MERCK PATENT GmbH (DE) | 1992-05-06 | — | — | EP | disclosed |
| JP-H02215769-A | NITROGEN-CONTAINING CYCLIC COMPOUNDS SUCH AS 1-(2-ARYLETHYL)-PYRROLIDINE | MERCK PATENT GMBH | 1990-08-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247472-A1 | Method for purifying quaternary onium salts | NHERF1, SCN7A, HCN4 | HRH3 3532/4885GNAI3 2010/4885GNAO1 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.